Please login to the form below

Not currently logged in
Email:
Password:

PMHub

Welcome to PMHub, a unique resource brought to you by PMLive and designed to enable the Pharmaceutical industry’s key suppliers to present you with all the information you need to make an informed selection.
You will find a mix of in-depth profile, news, thought leadership and whitepapers within PMHub. If you are looking to find a company based on a particular area then please use the ‘profile’ search which will return a list of key companies offering the skills you are looking for.
If you are looking for a partner with a particular understanding or expertise then we recommend using the ‘resources’ search – which delivers a set of results based on the understanding and knowledge uploaded by the industry’s specialist agencies and suppliers.
If you are a supplier and would like to be included within PMHub please click the ‘Add my Company’ link below.

PMHub Profile Search

Add my company

Categories

Featured jobs

Latest content from PMHub

The patient will see you now
GCI Health’s Laura Starr and Chris Bath report on how the dawning era of mobile tech and the ‘Internet of Things’ has transformed the health and wellness arena. GCI Health
90TEN Healthcare appointed to launch national STI service at Chelsea and Westminster
Chelsea and Westminster Hospital NHS Foundation Trust, which runs the largest specialist HIV hub in Europe, has appointed 90TEN Healthcare to launch its new sexual health online-postal service. 90TEN was selected following a competitive four-way pitch and the appointment further expands the consultancy’s decade-long partnership with the organisation. Its remit will include brand creation as well as marketing communications for the new service. 90TEN Healthcare
When forecasters take the floor: 6 tips on presenting a forecast
Peter Mansell queries some of pharma’s leading forecasters for their dos and don’ts on presenting a forecast Black Swan Analysis
Enablers of drug innovation could lie in the numbers
Christopher Ehinger of Black Swan Analysis addresses the problem of clinical-trial recruitment as a barrier to new drug development and offers a new way of looking at the problem. Black Swan Analysis